// App-Quantinova.ai

199 : Elevated Plasma Interleukin-6, Endothelin-1, and Matrix Metalloproteinase-9 in Heart Failure Patients are Associated With the Need for Advanced Therapies and Mortality

Researchers

Presenter

  • Eitan A. Friedman

Principal Investigators

  • Ugochukwu O. Egolum

  • David C. Shisler

  • John A. Todd

  • Joel Estis

  • Niamh Nolan

  • Adnan Shah

  • Daniel J. Lenihan

Medical Centers

  • Singulex, Inc., Alameda, CA

  • Vanderbilt University, Nashville, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Congestive heart failure

Biomarkers

  • Acetyl-CoA carboxylase

  • B-type natriuretic peptide

  • Endothelin-1

  • Interleukin 6

  • Matrix metallopeptidase 9

Drug/Treatment

  • ILS-969

  • endothelin-1

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved